155 results
Page 4 of 8
8-K
EX-10.7
y8f1cxij8dagdg3e 73
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
q4wzekl0
21 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
egcyf3 jgrd
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.1
6l3b79vn xraa0hlah
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.5
vu36ctkh3w9ngm4
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.4
85s5awt 185tbq4on
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.2
0thodqzd2qez8jgl0wd
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.6
khjajcmd egj
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.1
uhzwxwc5book
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hais1vqqsdjq 1v
26 Aug 16
Financial Statements and Exhibits
12:00am